These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 3888202)
1. Effect of islet cell surface antibodies on neonatal rat pancreatic islet cells or isolated islets of Langerhans in vitro. Schröder D; Hehmke B; Kohnert KD; Fiebach H; Jenssen HL; Besch W Biomed Biochim Acta; 1985; 44(1):107-15. PubMed ID: 3888202 [TBL] [Abstract][Full Text] [Related]
2. Effects of islet cell surface antibodies on isolated neonatal rat islets of Langerhans in vitro. Schröder D; Kohnert KD; Hehmke B; Besch W Allerg Immunol (Leipz); 1986; 32(2):111-21. PubMed ID: 2942021 [TBL] [Abstract][Full Text] [Related]
3. Absence of cytotoxicity of islet cell surface antibodies in vivo despite complement-mediated cytotoxic effects to islet cells in vitro. Kohnert KD; Hehmke B; Fält K; Ziegler M Biomed Biochim Acta; 1984; 43(5):663-73. PubMed ID: 6206850 [TBL] [Abstract][Full Text] [Related]
4. Cytotoxic effects of islet cell surface antibodies. Hehmke B; Kohnert KD; Dietz H; Zühlke H Acta Biol Med Ger; 1982; 41(12):1117-22. PubMed ID: 6765153 [TBL] [Abstract][Full Text] [Related]
5. Effect of serum from diabetes-prone BB/OK rats on neonatal rat pancreatic islets and islet cell suspensions. Schröder D; Hehmke B; Klöting I; Besch W Exp Clin Endocrinol; 1989 May; 93(2-3):187-92. PubMed ID: 2673813 [TBL] [Abstract][Full Text] [Related]
6. Antibody-dependent cell-mediated cytotoxicity of mononuclear cells against Langerhans islets of Wistar rats in normal man and in patients at diabetes risk. Köhler E; Knospe S; Woltanski G; Maciejewski R; Salzsieder C; Rjasanowski I; Strese J; Michaelis D Biomed Biochim Acta; 1984; 43(5):627-33. PubMed ID: 6383366 [TBL] [Abstract][Full Text] [Related]
7. Complement-dependent antibody-mediated cytotoxicity (C'AMC) to pancreatic islet cells in the spontaneously diabetic BB/OK rat: interference from cell-bound and soluble inhibitors. Hehmke B; Schröder D; Klöting I; Kohnert KD J Clin Lab Immunol; 1991 Jun; 35(2):71-81. PubMed ID: 1668761 [TBL] [Abstract][Full Text] [Related]
8. In vitro lysis of islet cells by lymphocytes from diabetic BB/Wor rats is not antibody mediated. Koevary SB Diabetes Res; 1990 Mar; 13(3):133-8. PubMed ID: 2091881 [TBL] [Abstract][Full Text] [Related]
9. Islet transplantation in experimental diabetes of the rat. X. Induction of cytotoxic antibodies and islet-cell-surface-antibodies after homologous islet transplantation in rats. Zekorn T; Bretzel R; Federlin K Horm Metab Res; 1985 Oct; 17(10):541-3. PubMed ID: 3934059 [TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of monoclonal antibodies against pancreatic beta cells. Ziegler B; Witt S; Waterstradt B; Schlosser M; Ziegler M Exp Clin Endocrinol; 1989 May; 93(2-3):173-80. PubMed ID: 2673811 [TBL] [Abstract][Full Text] [Related]
11. Studies on the correlation between the presence of cytotoxic islet cell surface antibody and the incidence of overt diabetes in BB rats. Tanguay KE; Yoon JW; Hart DA Diabetes Res; 1988 Aug; 8(4):171-5. PubMed ID: 3069281 [TBL] [Abstract][Full Text] [Related]
12. Detection of islet cell surface antibodies using cloned beta cells and comparison of their incidence with that of islet cell cytoplasmic antibodies. Grant AM; Harrison DE; Moysey L; Smith D; Ashcroft SJ Diabetes Res; 1985 Sep; 2(5):225-9. PubMed ID: 3905186 [TBL] [Abstract][Full Text] [Related]
13. CELISA for rapid screening of monoclonal islet cell surface antibodies using living rat insulinoma cells as target. Ziegler B; Schlosser M; Fürll B; Witt S; Ziegler M Diabetes Res; 1991 Jan; 16(1):41-5. PubMed ID: 1818797 [TBL] [Abstract][Full Text] [Related]
14. Immune islet killing mechanisms associated with insulin-dependent diabetes: in vitro expression of cellular and antibody-mediated islet cell cytotoxicity in humans. Charles MA; Suzuki M; Waldeck N; Dodson LE; Slater L; Ong K; Kershnar A; Buckingham B; Golden M J Immunol; 1983 Mar; 130(3):1189-94. PubMed ID: 6337213 [TBL] [Abstract][Full Text] [Related]
16. Islet cell cytoplasmic and surface antibodies' prevalence and beta cell specificity of islet cell surface antibodies in some subjects with putative islet cell autoimmunity. Keilacker H; Hildmann W; Wassmann C; Schade J; Kohnert KD; Strese J; Michaelis D; Ziegler M Biomed Biochim Acta; 1984; 43(5):657-61. PubMed ID: 6383370 [TBL] [Abstract][Full Text] [Related]
17. Detection of antibodies to islet cell and splenic lymphocytes in diabetes-prone BB and adjuvant-streptozotocin treated Lewis rats by ELISA and immunoblot analysis. Kohnert KD; Besch W; Schröder D; Ziegler B; Hehmke B; Fält K; Ziegler M Allerg Immunol (Leipz); 1990; 36(4):321-31. PubMed ID: 2097900 [TBL] [Abstract][Full Text] [Related]
18. Flow cytometric analysis of monoclonal islet cell surface antibodies reacting with RINm5AH insulinoma cells. Vissing H Biomed Biochim Acta; 1985; 44(1):123-7. PubMed ID: 3888204 [TBL] [Abstract][Full Text] [Related]
19. Cytotoxicity of MHC antisera against rat islets: detection by release of 51Cr and leakage of hormones. Kuttler B; Klöting I; Schmidt S Diabetes Res; 1985 Mar; 2(2):77-80. PubMed ID: 3899463 [TBL] [Abstract][Full Text] [Related]
20. Multiple reactivities of cytotoxic monoclonal antibodies against pancreatic islet cells. Suzuki M; Sharma B; Waldeck N; Charles MA Diabetes Res; 1984 Nov; 1(4):179-81. PubMed ID: 6397292 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]